New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine
Summary
The FDA has approved a new flu vaccine called mFlusiva that uses mRNA technology, similar to the COVID-19 vaccines. This flu shot is for adults 50 and older and will soon be available at some stores.Key Facts
- The FDA approved Moderna’s mRNA-based flu vaccine named mFlusiva.
- The vaccine is designed for adults aged 50 and over.
- mRNA technology was important in ending the COVID-19 pandemic.
- Other flu vaccines are already available in pharmacies before the fall season.
- Moderna expects to release its vaccine soon at select retailers.
- Multiple flu vaccine options exist, including three made for people 65 and older.
- Influenza causes tens of thousands of deaths in the U.S. each year.
- Older adults are more at risk from the flu.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
